12:00 AM
 | 
Jan 23, 2012
 |  BC Week In Review  |  Company News  |  Deals

Ista, Valeant Pharmaceuticals deal

Valeant increased its unsolicited offer to acquire ophthalmic company Ista to $7.50 per share from $6.50. The new price is a 93% premium to Ista's close of $3.89 on Dec. 15, 2011, the day before the initial offer was made public. Valeant added it could potentially raise the offer to $8.50 per share if Ista provides confirmatory due diligence that supports the higher price. Valeant said...

Read the full 310 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >